(Q46344539)

21 December 2017

title

PARP inhibitors and cancer therapy - early results and potential applications (English)

1 reference

21 December 2017

author name string

C Jones

series ordinal

1

1 reference

21 December 2017

E R Plummer

series ordinal

2

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

21 December 2017

British Journal of Radiology

published in

1 reference

21 December 2017

volume

81 Spec No 1

1 reference

21 December 2017

page(s)

S2-5

1 reference

21 December 2017

Endogenous mutagens and the causes of aging and cancer

cites work

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F30872348

Genome maintenance mechanisms for preventing cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F30872348

Novel inhibitors of poly(ADP-ribose) synthetase

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F30872348

Poly(ADP-ribose) polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F30872348

Potentiation of anti-cancer agent cytotoxicity by the potent poly(ADP-ribose) polymerase inhibitors NU1025 and NU1064.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F30872348

Potentiation of temozolomide-induced cytotoxicity: a comparative study of the biological effects of poly(ADP-ribose) polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F30872348

Chemopotentiation of temozolomide, irinotecan, and cisplatin activity by CEP-6800, a poly(ADP-ribose) polymerase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F30872348

Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F30872348

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F30872348

Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F30872348

Temozolomide pharmacodynamics in patients with metastatic melanoma: dna damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F30872348

Hallmarks of 'BRCAness' in sporadic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F30872348

(ADP-ribose)n participates in DNA excision repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F30872348

21 January 2018

Identifiers

DOI

10.1259/BJR/30872348

1 reference

21 December 2017

PubMed ID

18819994

1 reference

21 December 2017